Data / Drug companies / Chain Drug Marketing Association
Chain Drug Marketing Association: 208 products in the FDA NDC directory, labeler code 63868
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Chain Drug Marketing Association (labeler code 63868) lists 208 products in the FDA National Drug Code Directory, covering 111 finished drugs by generic name. By type: 208 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on January 1, 2024.
The request: Watch Chain Drug Marketing Association (FDA labeler code 63868): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 63868
- Products in commercial distribution
- 208
- Packages
- 255
- Finished drugs by generic name
- 111
- Prescription products
- 0
- Over the counter products
- 208
- Flagged as original packager
- 163 of 163 products that carry the flag
- Started marketing in the last 12 months
- 0
- Products with a marketing end date set
- 59
- Earliest marketing start
- January 1, 1979
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 160 | 76.9% |
| Generic drugs (ANDA) | 36 | 17.3% |
| New drug applications (NDA) | 6 | 2.9% |
| Other unapproved drugs | 4 | 1.9% |
| Unapproved homeopathic products | 2 | 1% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 208 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Liquid | 34 | 16.3% |
| Tablet, coated | 26 | 12.5% |
| Tablet | 24 | 11.5% |
| Capsule, liquid filled | 16 | 7.7% |
| Tablet, chewable | 14 | 6.7% |
| Suspension | 10 | 4.8% |
| Tablet, film coated | 10 | 4.8% |
| Spray | 7 | 3.4% |
| Lotion | 6 | 2.9% |
| Solution | 6 | 2.9% |
| Gel | 6 | 2.9% |
| Capsule | 5 | 2.4% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Quality Choice | 63868-963 | Swab | Over the counter monograph drugs | January 1, 2024 |
| Acetaminophen | 63868-809 | Syrup | Over the counter monograph drugs | July 1, 2023 |
| Maximum Strength Gas Relief | 63868-975 | Capsule, liquid filled | Over the counter monograph drugs | March 28, 2023 |
| Quality Choice Nighttime Sleep-Aid | 63868-970 | Capsule, liquid filled | Over the counter monograph drugs | March 28, 2023 |
| Quality Choice Extra Strength Assorted Berry Antacid Extra strength Assorted Berry Antacid | 63868-155 | Tablet, chewable | Over the counter monograph drugs | August 15, 2022 |
| Head Congestion Mucus PE | 63868-103 | Tablet, coated | Over the counter monograph drugs | August 3, 2022 |
| Head Congestion Flu Severe PE | 63868-102 | Tablet, coated | Over the counter monograph drugs | August 3, 2022 |
| QC Regular Strength | 63868-130 | Tablet, chewable | Over the counter monograph drugs | July 15, 2022 |
| Quality Choice Stool Softener laxative | 63868-662 | Capsule, liquid filled | Over the counter monograph drugs | January 19, 2022 |
| Stool Softener Laxative | 63868-638 | Capsule, liquid filled | Over the counter monograph drugs | December 30, 2021 |
| QC SPF 30 Sunscreen | 63868-913 | Lotion | Over the counter monograph drugs | December 22, 2021 |
| QC SPF 50 Sunscreen | 63868-531 | Lotion | Over the counter monograph drugs | December 22, 2021 |
| QC Cool and Heat Roll-On | 63868-511 | Liquid | Over the counter monograph drugs | December 16, 2021 |
| Dye-Free Ibuprofen | 63868-805 | Capsule, liquid filled | Generic drugs (ANDA) | November 16, 2021 |
| Advanced Hand Sanitizer | 63868-882 | Gel | Over the counter monograph drugs | October 5, 2021 |
| 12 Hour Mucus Relief | 63868-149 | Tablet, extended release | Generic drugs (ANDA) | September 17, 2021 |
| Maximum Strength Mucus Relief | 63868-148 | Tablet, extended release | Generic drugs (ANDA) | September 17, 2021 |
| QC Scar | 63868-271 | Gel | Over the counter monograph drugs | August 16, 2021 |
| Allergy Relief | 63868-333 | Tablet | Over the counter monograph drugs | July 8, 2021 |
| Allergy Relief | 63868-334 | Tablet | Generic drugs (ANDA) | July 6, 2021 |
| Low Dose Aspirin | 63868-332 | Tablet, chewable | Over the counter monograph drugs | July 2, 2021 |
| Ibuprofen PM | 63868-829 | Capsule, liquid filled | Generic drugs (ANDA) | June 11, 2021 |
| Naproxen Sodium | 63868-830 | Capsule, liquid filled | New drug applications (NDA) | June 3, 2021 |
| Ibuprofen | 63868-268 | Tablet, coated | Generic drugs (ANDA) | May 31, 2021 |
| Night Time Cold and Flu Multi Symptom | 63868-737 | Capsule, liquid filled | Over the counter monograph drugs | April 30, 2021 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.